Noot Walter, Chief Operating Officer of USANA Health Sciences (USNA), has demonstrated a consistent pattern of selling activity over the past several years, with no recorded purchases of company stock. According to SEC Form 4 filings, Walter has executed 28 transactions totaling $747,587 in sales, all involving USNA shares. The most significant single sale occurred on March 8, 2024, when Walter disposed of shares worth $257,022. Smaller but repeated sales followed in February 2025 and February 2026, with transactions ranging from $17,349 to $67,659, often clustered within consecutive trading days—such as the series of sales between February 6-8, 2026, totaling $88,774.
The filings indicate that Walter’s transactions are primarily coded as "F" (dispositions to cover tax obligations) rather than open-market sales ("S"), suggesting these sales may be tied to equity compensation vesting events. Notably, the absence of any buy transactions—coupled with the recurring pattern of sales—points to a steady reduction in Walter’s position in USNA. While the sales are relatively modest compared to the March 2024 transaction, their frequency and timing around annual vesting periods suggest a systematic approach to liquidating shares rather than a reaction to short-term market conditions. The data reflects a clear directional bias toward divestment without any offsetting accumulation of shares.
AI-assisted summary